News
Kiland’s two-pronged pivot after 2020 bushfire loss
Every second week we invite a leading fund manager to present at The Insider: Meet the Fund Manager. In September 2022, Hancock & Gore’s Joseph Constable selected Kiland as one of his favourite stocks for the ‘asymmetric upside’ of its…
Markets cautious ahead of wages data reaching 5-week lows
The market has pulled back from recent highs and today is trading at the 50 day moving average, a key support level that is currently being tested and represents an important inflection point. After the ASX 200 got close to breaking an all time high, this bullish price action is now being tested and we will be watching to see if a reversal occurs.
Tesla not the only Electric Vehicle maker shaking up the renewables industry
Since Tesla released its first electric vehicle, the Roadster, back in 2008, the company has been at the forefront of EV innovations for the past 15 years. While Tesla is still well ahead in terms of market share, there are some new players in the clean energy space.
Multiple rare earth discoveries the key for a greener future
With the discovery of 1 million tonnes of rare earth oxides in Sweden’s north, the largest deposit of its kind found in Europe, Swedish firm LKAB has made a significant breakthrough in the rare earths space.
Argentine artist tackles inflation woes with a paint-by-numbers solution
High inflation has hit many countries hard in recent times. One country has had a particularly tough time: Argentina. With three decade high year-on-year inflation at 98.8% in January, up 6% from December, few countries have it that bad.
Spectur completes acquisition of AI business, solidifies offering
Australian surveillance and security company Spectur Limited (ASX: SP3) has acquired 3 Crowns Technologies (3CT), giving the former control of the artificial intelligence technology business with integration set to commence in the week of 20 February 2023.
PTX-100 shows encouraging efficacy signals and safety in area of high unmet clinical need
Clinical stage oncology company, Prescient Therapeutics, has a diverse stable of emerging and later stage assets across CAR-T and targeted cell therapies. The company has recently had significant developments with their targeted cell therapy PTX-100
FEG discovers two new veins, presses on with Phase 2 drilling
Aussie explorer Fast East Gold Limited (ASX: FEG) has revealed two new vein discoveries within its highly prospective Woyla project in Indonesia, which has returned bonanza grade gold and silver assay results and is gaining momentum with its Phase 2 drill program.
FEG edges closer to bonanza-grade project’s potential
Australian junior explorer Far East Gold (ASX: FEG) has announced the results of preliminary metallurgical tests from its flagship Woyla project in Indonesia which returned 91% for gold and 86% for silver.
Australians ability to ‘weather the storm’ is in doubt
The impact of rising interest rates on consumer spending is starting to be felt by the market, as this quarter’s earnings reports are showing signs of reduced household spare cash flows, which is impacting economic activity.
Me, Myself and AI: Will humanity embrace its technological twin?
For something that mimics the intelligence of the average pigeon, artificial intelligence (AI) has spread its wings and swooped in on virtually every aspect of human existence from generating Beethoven’s symphony to help a judge make a court ruling.
Wellnex Life targets over-the-counter space with brand launch
Australian health and wellness business Wellnex Life (ASX: WNX) aims to build a notable presence in the over-the-counter pharmaceutical space with the launch of its wholly-owned Pharmacy Own brand of health and wellness products.
Connecting quality investors and innovative companies to facilitate mutual wealth creation with trust and transparency
Receive the latest news and media directly to your inbox
By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.